Aligos Therapeutics, Inc. (ALGS) vs aTyr Pharma, Inc. (ATYR)
Aligos Therapeutics, Inc. and aTyr Pharma, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and aTyr Pharma, Inc. are of similar size ($32.6M and $31.4M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 893.0% against 6.78%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −241.0%) and the higher return on invested capital (0.00% vs −3,379.3%). Across the 17 metrics below, aTyr Pharma, Inc. leads on 9 and Aligos Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | ALGS | ATYR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 1.72% | 65.16% |
| Operating margin | (250.63%) | 0.00% | 0.00% |
| Net margin | (241.01%) | 0.00% | 0.00% |
| Free cash flow margin | (299.90%) | 0.00% | 0.00% |
| Return on equity | (113.59%) | (98.67%) | (57.72%) |
| Return on assets | (75.57%) | (70.97%) | (49.22%) |
| Return on invested capital | (3,379.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack